The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.
"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...
Developed through PCF’s Clinician-Industry Roundtable, a collaboration among physician-scientists and industry experts dedicated to improving prostate cancer treatment and care – The Prostate Cancer ...
Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...
Kevin Mortimer has been described as a 'super responder' to triplet therapy - a method that attacks the cancer with three treatments at once.
Prostate cancer is the second most commonly diagnosed cancer among men worldwide, with an estimated 1.55 million new cases in ...
Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...
A new Nature study shows that the dosage of a single transfer RNA, tRNA1Arg(UCU), acts as a reversible molecular switch ...
A large international registry study finds that while 58 to 63 percent of men with advanced prostate cancer meet aerobic ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) today announce a collaboration to advance new prostate ...
New data shows that men diagnosed with incurable advanced prostate cancer are living longer.